Publications by authors named "Annette Fasan"

Claim this Profile
T
Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective.
Agnes Kisser, Joschua Knieriemen, Annette Fasan, Karolin Eberle, Sara Hogger

Eur J Health Econ· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients.
Alexander Höllein, Sabine Jeromin, Manja Meggendorfer, Annette Fasan, Niroshan Nadarajah

Leukemia· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia.
Raphael Itzykson, Nicolas Duployez, Annette Fasan, Gauthier Decool, Alice Marceau-Renaut

Blood· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.
Kristina von Heyking, Julia Calzada-Wack, Stefanie Göllner, Frauke Neff, Oxana Schmidt, Annette Fasan

Mol Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular landscape of acute promyelocytic leukemia at diagnosis and relapse.
Annette Fasan, Claudia Haferlach, Karolina Perglerovà, Wolfgang Kern, Torsten Haferlach

Haematologica· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.
Chiara Elena, Anna Gallì, Esperanza Such, Manja Meggendorfer, Ulrich Germing, Annette Fasan

Blood· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of IDH1G105 polymorphism as prognostic marker in intermediate-risk AML.
Annette Fasan, Claudia Haferlach, Christiane Eder, Tamara Alpermann, Anne Quante

Ann Hematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases.
Annette Fasan, Claudia Haferlach, Alexander Kohlmann, Frank Dicker, Christiane Eder

Haematologica· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases.
Annette Fasan, Tamara Alpermann, Claudia Haferlach, Vera Grossmann, Andreas Roller

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis.
Vera Grossmann, Claudia Haferlach, Niroshan Nadarajah, Annette Fasan, Sandra Weissmann

Br J Haematol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1.
Günther H S Richter, Annette Fasan, Kristina Hauer, Thomas G P Grunewald, Colette Berns

J Pathol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intact LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft.
Norbert Hüser, Annette Fasan, Monika Semmrich, Patricia Schmidbauer, Bernhard Holzmann

Int Immunol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation.
Günther H S Richter, Stephanie Plehm, Annette Fasan, Sabine Rössler, Rebekka Unland

Proc Natl Acad Sci U S A· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-course of radiation-induced chromosomal aberrations in tumor patients after radiotherapy.
Irene Müller, Hans Geinitz, Herbert Braselmann, Adolf Baumgartner, Annette Fasan

Int J Radiat Oncol Biol Phys· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis